National Public Radio

Kaeberlein is no stranger to rapamycin. He’s a biologist and co-founded the Dog Aging Project to study how rapamycin influences dogs’ healthspans. He’s also the former director of the Healthy Aging and Longevity Research Institute at the University of Washington.